<DOC>
	<DOCNO>NCT00327132</DOCNO>
	<brief_summary>1 . The complete histological molecular remission rate antibiotic 1st-line therapy Hp-positive early-stage gastric lg- hg-MALT lymphoma 2 . The durability complete histological remission antibiotic 3 . The usefulness pattern NF-kB BCL-10 IHC stain prospectively predict Hp-dependence gastric lg- hg-MALT lymphoma 4 . The frequency ( 11 ; 18 ) translocation gastric lg- hg-MALT lymphoma Taiwan . 5 . The association CYP2C18/19 genetic polymorphism eradication Hp infection antibiotic .</brief_summary>
	<brief_title>Prospective Study First-line Antibiotic Therapy Early-stage Gastric MALT Lymphoma Treatment Outcome</brief_title>
	<detailed_description>Background : Eradication Helicobacter pylorus ( Hp ) infection well recognize initial therapy early-stage low-grade gastric mucosa-associated lymphoid tissue-type lymphoma ( lg-MALT lymphoma ) . On hand , high-grade transform MALT lymphoma ( hg-MALT lymphoma ) generally consider arise Hp-independent clone thus unlikely respond antibiotic therapy . Our previous prospective study firstly demonstrate 1st-line antibiotic therapy could achieve durable complete histological remission two-third Hp-positive stage IE hg-MALT lymphoma ( Chen et al. , J. Clin . Oncol. , 2001 ) , long-term clinical outcome equivalent achievable lg-MALT lymphoma ( Chen et al . J Natl Cancer Inst , accept ) . In addition , laboratory study confirm ( 11 ; 18 ) translocation associate loss Hp-dependence lg-MALT lymphoma infrequently find high-grade tumor . We also find nuclear translocation NF-kB BCL-10 ( immunohistochemical , IHC , stain ) useful marker predict Hp-dependence early-stage gastric hg- lg-MALT lymphoma antibiotic therapy ( Kuo et al . JCO 2004 &amp; Yeh et al . Blood 2005 ) . In addition , recent data suggest cytochrome CYP2C18/19 genetic polymorphism associate metabolism omeprazole , thus genotype enzyme might affect efficacy antibiotic eradication Hp infection . Aims : A nationwide study prospectively validate 1 . The complete histological molecular remission rate antibiotic 1st-line therapy Hp-positive early-stage gastric lg- hg-MALT lymphoma 2 . The durability complete histological remission antibiotic 3 . The usefulness pattern NF-kB BCL-10 IHC stain prospectively predict Hp-dependence gastric lg- hg-MALT lymphoma 4 . The frequency ( 11 ; 18 ) translocation gastric lg- hg-MALT lymphoma Taiwan . 5 . The association CYP2C18/19 genetic polymorphism eradication Hp infection antibiotic . Materials Methods : Patients newly , histologically proven stage IE / IIE-1 gastric lg- hg-MALT lymphoma eligible . Pre-treatment Hp infection status determine histology , rapid urease test serology . At time registration , patient agree provide endoscopic biopsy specimen , include eight 4-mm histologic section immunohistochemical study NF-kB BCL-10 three 10-mm section eppendorf tube RNA extraction subsequent RT-PCR ( 11 ; 18 ) translocation determination , perform central laboratory . In addition , serum ( 5 mL coagulate blood ) well peripheral blood mononuclear cell ( 3 mL heparized blood ) also collect treatment Hp-serology CYP 2C18/19 genetic polymorphism detection , respectively . Hp-positive patient receive 2-week triple therapy , consist omeprazole , amoxicillin clarithromycin ( OAC regimen ) , first follow-up endoscopy 4 week later determine status Hp infection tumor response . Patients sequential follow-up endoscopic examination every 3 month complete histological remission ( CR ) disease progression ; every 6 month complete responder . Patients hg-MALT lymphoma stable progressive disease Hp eradication immediately refer systemic chemotherapy . CR define regression lymphoid infiltration Wotherspoon 's score &lt; 2 pathological section endoscopic biopsy specimen . The predictive value NF-kB , BCL-10 ( 11 ; 18 ) complete histological remission Hp eradication determine . Expected Results : 1st-line antibiotic therapy achieve complete histologic remission 70-80 % Hp-positive stage IE gastric lg-MALT lymphoma 50-60 % stage IE hg-MALT lymphoma . The objective histologic CR rate stage IIE-1 disease may 30-40 % low-grade tumor 20-30 % high-grade one . The sensitivity specificity NF-kB BCL-10 positive nuclear stain IHC ( 11 ; 18 ) predict Hp-independence 80 - 90 % . Ten - twenty per cent enrol patient CYP2C19 m1/m1 , m1/m2 m2/m2 genotype ( consider omeprazole poor metabolizer ) , might high Hp eradication rate extensive metabolizers .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell , Marginal Zone</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>The patient must histologically confirm primary gastric MALT lymphoma without cluster large cell ( extranodal marginal zone lymphoma , diffuse large cell lymphoma feature MALT REAL/WHO classification , Harris NL et al . 1994 ) . 1.1 The diagnosis primary gastric lymphoma must fulfill criterion Dawson [ 38 ] . ( 1 ) No enlargement peripheral mediastinal lymph node ; ( 2 ) Peripheral blood smear reveal leukemic lymphomatous abnormality ; ( 3 ) Predominant alimentary tract lesion adenopathy correspond accept lymphatic drainage route ; ( 4 ) No involvement liver spleen except extension contiguous disease . 1.2 The diagnosis MALT lymphoma make histopathologists individual hospital , accordance criterion define Isaacson et al . Chang et al , review member TCOG Pathology Committee . This pathology review mechanism function well previous T1296 study ( see J Natl Cancer Inst . 2005 ; 97:134553 ) 1.3 The patient must prior chemotherapy radiotherapy his/her gastric lg hgMALToma . Patients must evaluable disease endoscopy and/or nodal status compute tomography . Endoscopic ultrasonography ( EUS ) mandatory evaluate depth tumor infiltration status perigastric lymph node enlargement . Patients must document H. pylori infection treatment , evaluate follow test : histology , rapid urease test ( CLOtest ) , C13 urease breath test serology . 3.1 The following consider H. pylori infection : 4 test show positive result . Patients must either stage IE IIE1 disease , accord adaptation Ann Abor stag system modify Musshoff primary extranodal lymphoma . 4.1 Stage IE : lymphoma confine gastric wall without lymph node involvement . 4.2 Stage IIE : localize involvement one GI site ( ) one side diaphragm lymph node involvement , depth lymphoma infiltration gut wall . 4.21 Stage IIE1 : involvement perigastric lymph node . 4.22 Stage IIE2 : abdominal , beyond perigastric , lymph nodal involvement . Patient must sign informed consent agree provide achieve pathologic material immunohistochemical study RTPCR ( 11 ; 18 ) ( q21 ; q21 ) determination . Patients extensive gastrointestinal tract involvement eligible . Patients previous history extranodal lymphoma eligible . Patients stage IIE2 beyond disease : infiltration regional lymph node , e.g . paraaortic , renal hilar , retroperitoneal , mesenteric , lymph node gastrosplenic ligament hepatoduodenal ligament ; involvement lymph node diaphragm ( Stage III ) visceral organ involvement ( stage IV ) eligible . Patients cardiopulmonary status allow repeat endoscopy eligible . Patients prior antibiotic , chemo radiotherapy gastric lymphoma eligible . Patients previous antiH . pylori therapy without pretreatment pathology achieve material histological review immunohistochemical study eligible .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Early-stage Lg/Hg Gastric MALT Lymphoma</keyword>
	<keyword>Eradication Helicobacter pylorus ( Hp )</keyword>
</DOC>